ORNAV Orion Oyj Class B

HEL · FI · Healthcare · Drug Manufacturers - General · orionpharma.com

81.00EUR+0.75%Mkt Cap: 12.30B $P/E: 19.231d ago

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. It offers pharm…

Industry Peers

Drug Manufacturers - General

Screen all

LLY

Eli Lilly and Company Common Stock

$1.02TUSDP/E 38.4

JNJ

Johnson & Johnson Common Stock

$617.01BUSDP/E 29.7

ABBV

AbbVie Inc. Common Stock

$464.43BUSDP/E 74.2

MRK

Merck & Company, Inc. Common Stock (new)

Novartis AG Common Stock

AstraZeneca PLC Ordinary Shares

Amgen Inc. - Common Stock

Gilead Sciences, Inc. - Common Stock

$179.47BUSD

NVO

Novo Nordisk A/S Common Stock

$164.79BUSDP/E 9.4

PFE

Pfizer, Inc. Common Stock

$158.45BUSDP/E 36.6

BMY

Bristol-Myers Squibb Company Common Stock

$124.91BUSDP/E 13.5

SNY

Sanofi - American Depositary Shares

$95.65BUSDP/E 21.8

GSK

GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Key Statistics

Company

Market Cap12.30B USD

Enterprise Value12.31B USD

Revenue (TTM)2.24B USD

Gross Profit1.32B USD

Net Income (TTM)543.80M USD

Revenue/Share14.62 EUR

Last Price81.00 EUR

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees4.0K

CountryFI

SectorHealthcare

IndustryDrug Manufacturers - General

ISINFI0009014377

Valuation

P/E (Trailing)19.23

P/E (Forward)—

PEG5.73

EV/EBITDA14.27

EV/Revenue5.50

P/S5.50

P/B8.93

EPS (TTM)4.17

EPS (Forward)—

52W Range

56.3088% of range84.40

52W High84.40 EUR

52W Low56.30 EUR

Profitability

Gross Margin64.20%

Oper. Margin33.84%

EBITDA Margin38.58%

Profit Margin26.48%

ROE38.95%

ROA24.89%

Growth

Revenue Growth25.20%

Earnings Growth69.50%

Cash Flow & Leverage

Operating CF344.35M USD

CapEx (TTM)106.09M USD

FCF Margin13.06%

FCF Yield2.37%

Net Debt2.72M USD

Net Debt/EBITDA0.00

Balance Sheet

Debt/Equity0.24

Current Ratio2.64

Quick Ratio1.48

Book Value/Sh9.01 EUR

Cash/Share0.92 EUR

Dividends

Fwd Div Rate1.80 EUR

Trail. Div Rate1.80 EUR

Div. Yield2.24%

5Y Avg Yield2.97%

Payout Ratio41.25%

Ex-Div DateOct 19, 2026

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.31.27M

Float123.49M

Insiders32.76%

Institutions8.06%

Technical

SMA 5080.11 (+1.1%)

SMA 20071.96 (+12.6%)

Beta0.30

S&P 52W Chg14.58%

Avg Vol (30d)4.48K

Avg Vol (10d)4.97K

Technical Indicators

RSI (14)48.7

MACD0.7833

MACD Signal0.9818

MACD Hist.-0.1985

BB Upper84.48 EUR

BB Middle80.92 EUR

BB Lower77.37 EUR

BB Width8.79%

ATR (14)1.575 EUR

Vol Ratio (20d)0.48x